Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma.

[1]  P. Hopkins.  Pulp Infection of Fingers , 1944 .

[2]  D. Kupfer,et al.  Resting plasma catecholamine concentrations in patients with depression and anxiety. , 1971, Archives of general psychiatry.

[3]  S. Strandgaard,et al.  Autoregulation of Cerebral Blood Flow in Hypertensive Patients: The Modifying Influence of Prolonged Antihypertensive Treatment on the Tolerance to Acute, Drug‐induced Hypotension , 1976, Circulation.

[4]  L. Landsberg,et al.  Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II. , 1978, The American journal of medicine.

[5]  I. Kopin,et al.  Plasma levels of norepinephrine. , 1978, Annals of internal medicine.

[6]  M. Weinberger,et al.  Diagnosis and localization of pheochromocytoma. Detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-scan). , 1979, The American journal of medicine.

[7]  R W Gifford,et al.  Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. , 1981, The New England journal of medicine.

[8]  C. Dollery,et al.  INCREASED SENSITIVITY AND ACCURACY OF PHAEOCHROMOCYTOMA DIAGNOSIS ACHIEVED BY USE OF PLASMA-ADRENALINE ESTIMATIONS AND A PENTOLINIUM-SUPPRESSION TEST , 1981, The Lancet.

[9]  S. Ball,et al.  Circulating dopamine: its effect on the plasma concentrations of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. , 1981, Clinical science.

[10]  J. Ménard,et al.  Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. , 1981, British medical journal.

[11]  Burris Jf,et al.  Complications of clonidine suppression test for pheochromocytoma. , 1982 .

[12]  V. Dzau,et al.  Symptomatic hypotension following the clonidine suppression test for pheochromocytoma. , 1983, Archives of internal medicine.

[13]  M. Brown,et al.  Simultaneous assay of noradrenaline and its deaminated metabolite, dihydroxyphenylglycol, in plasma: a simplified approach to the exclusion of phaeochromocytoma in patients with borderline elevation of plasma noradrenaline concentration , 1984, European journal of clinical investigation.

[14]  E. Bravo,et al.  Current concepts. Pheochromocytoma: diagnosis, localization and management. , 1984, The New England journal of medicine.

[15]  A. Anton,et al.  Clonidine suppression test for pheochromocytoma: examples of misleading results. , 1986, The Journal of clinical endocrinology and metabolism.